147 related articles for article (PubMed ID: 36207724)
1. Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy.
Prosser W; Sagar K; Seidel M; Alva S
BMC Health Serv Res; 2022 Oct; 22(1):1237. PubMed ID: 36207724
[TBL] [Abstract][Full Text] [Related]
2. A Tale of 2 Countries: Implementation of the Cold Chain Equipment Optimization Platform in Guinea and Kenya.
Stammer E; Teklemariam L; Barry A; Millimono R; Chweya A; Danfakha N; Golia C; Herrera E; Patykewich L; Prosser W; Alva S
Glob Health Sci Pract; 2022 Oct; 10(5):. PubMed ID: 36316144
[TBL] [Abstract][Full Text] [Related]
3. Seizing market shaping opportunities for vaccine cold chain equipment.
Azimi T; Franzel L; Probst N
Vaccine; 2017 Apr; 35(17):2260-2264. PubMed ID: 28364940
[TBL] [Abstract][Full Text] [Related]
4. Deployment of vaccine cold chain equipment in resource-limited settings: lessons from the Gavi Cold Chain Optimization Platform in Cameroon.
Nkwain J; Zambou VM; Nchinjoh SC; Agbor VN; Adidja A; Mbanga C; Edwidge NN; Ndoula ST; Andreas AN; Diack D; Di Mattei P; Wiwa O; Diaby O; Saidu Y
Int Health; 2024 Feb; ():. PubMed ID: 38333954
[TBL] [Abstract][Full Text] [Related]
5. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
Gandhi G
BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
[TBL] [Abstract][Full Text] [Related]
6. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
7. Redesigning immunization supply chains: Results from three country analyses.
Prosser W; Folorunso O; McCord J; Roche G; Tien M; Hatch B; Spisak C; Genovese E; Pare B; Donatien K; Ibrahim M; Abou-Charaf E; Wright C; Dubourg JC
Vaccine; 2021 Apr; 39(16):2246-2254. PubMed ID: 33752952
[TBL] [Abstract][Full Text] [Related]
8. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
9. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
10. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
11. Thinking outside of the [cold] box: implementing a human-centered design approach to understand barriers and craft solutions to cold chain equipment maintenance in Niger.
Prosser W; Danfakha N; Thurston B; Gueye A; Matan S; Tidiane C; Kitts E; Alkassoum I; Agui Y; Brah-Bouzou A; Dembo H; Garba M
J Pharm Policy Pract; 2023 Nov; 16(1):146. PubMed ID: 37974256
[TBL] [Abstract][Full Text] [Related]
12. Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.
Dadari I; Higgins-Steele A; Sharkey A; Charlet D; Shahabuddin A; Nandy R; Jackson D
Vaccine; 2021 Apr; 39(17):2434-2444. PubMed ID: 33781603
[TBL] [Abstract][Full Text] [Related]
13. Challenges to sustainable immunization systems in Gavi transitioning countries.
Cernuschi T; Gaglione S; Bozzani F
Vaccine; 2018 Oct; 36(45):6858-6866. PubMed ID: 30268735
[TBL] [Abstract][Full Text] [Related]
14. Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction.
Soble A; Patel Z; Sosler S; Hampton L; Johnson H
Clin Infect Dis; 2020 Jul; 71(Suppl 2):S160-S164. PubMed ID: 32725236
[TBL] [Abstract][Full Text] [Related]
15. Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.
Lennon P; Atuhaire B; Yavari S; Sampath V; Mvundura M; Ramanathan N; Robertson J
Vaccine; 2017 Apr; 35(17):2198-2202. PubMed ID: 28364931
[TBL] [Abstract][Full Text] [Related]
16. The people factor: An analysis of the human resources landscape for immunization supply chain management.
Kasonde M; Steele P
Vaccine; 2017 Apr; 35(17):2134-2140. PubMed ID: 28364921
[TBL] [Abstract][Full Text] [Related]
17. Perspective and investments in health system strengthening of Gavi, the Vaccine Alliance: a content analysis of health system strengthening-specific funding.
Tsai FJ; Lee H; Fan VY
Int Health; 2016 Jul; 8(4):246-52. PubMed ID: 26612851
[TBL] [Abstract][Full Text] [Related]
18. Challenges to implementing Gavi's health system strengthening support in Chad and Cameroon: results from a mixed-methods evaluation.
Dansereau E; Miangotar Y; Squires E; Mimche H; ; ; El Bcheraoui C
Global Health; 2017 Nov; 13(1):83. PubMed ID: 29145871
[TBL] [Abstract][Full Text] [Related]
19. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
[TBL] [Abstract][Full Text] [Related]
20. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
